Chemoinformaics analysis of 9-Octylheptadecane
Molecular Weight | 352.691 | nRot | 21 |
Heavy Atom Molecular Weight | 300.275 | nRig | 2 |
Exact Molecular Weight | 352.407 | nRing | 0 |
Solubility: LogS | -4.544 | nHRing | 0 |
Solubility: LogP | 4.472 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 77 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 52 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 25 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 76.4232 |
nHD | 0 | BPOL | 52.1668 |
QED | 0.475 |
Synth | 2.888 |
Natural Product Likeliness | 1.552 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.665 |
Pgp-sub | 0.003 |
HIA | 0.003 |
CACO-2 | -4.376 |
MDCK | 0.0000251 |
BBB | 0.401 |
PPB | 0.968543 |
VDSS | 1.576 |
FU | 0.034718 |
CYP1A2-inh | 0.977 |
CYP1A2-sub | 0.255 |
CYP2c19-inh | 0.707 |
CYP2c19-sub | 0.5 |
CYP2c9-inh | 0.542 |
CYP2c9-sub | 0.715 |
CYP2d6-inh | 0.041 |
CYP2d6-sub | 0.113 |
CYP3a4-inh | 0.14 |
CYP3a4-sub | 0.216 |
CL | 15.311 |
T12 | 0.435 |
hERG | 0.018 |
Ames | 0.004 |
ROA | 0.012 |
SkinSen | 0.943 |
Carcinogencity | 0.226 |
EI | 0.933 |
Respiratory | 0.241 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.749581 |